Turn Therapeutics Inc. Common Stock TTRX Income Statement
| FY'25 | ||
|---|---|---|
| $265.57K— | ||
| $5.59M— | ||
| $5.86M— | ||
| $5.86M— | ||
| -$5.86M— | ||
| $29.58K— | ||
| $2.66M— | ||
| $2.57M— | ||
| —— | ||
| —— | ||
| —— | ||
| —— | ||
| —— | ||
| -$380.44K— | ||
| —— | ||
| -$5.86M— | ||
| -$5.81M— | ||
| -$5.81M— | ||
| -$5.86M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Turn Therapeutics Inc. Common Stock profitable?
- Turn Therapeutics Inc. Common Stock is not currently profitable: it reported a net loss of $3.5M over the trailing twelve months.
- What is Turn Therapeutics Inc. Common Stock's earnings per share?
- Turn Therapeutics Inc. Common Stock's diluted EPS over the trailing twelve months is $-0.13.
- Where does Turn Therapeutics Inc. Common Stock's income statement data come from?
- Every line is extracted from Turn Therapeutics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.